Pharmacogenomics: Convergence of Pharmacology & Genomics
Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor. Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating a personalized cancer screening and treatment plan includes: Determining the chances that a person will develop cancer and selecting screening strategies to lower the risk, Matching patients with treatments that are more likely to be effective and cause fewer side effects, Predicting the risk of recurrence (return of cancer)
- Predictive computational phenotyping
- New era of Proteomics
- Drug metabolizing enzymes
- Protein microarrays for personalized medicine
- Genotyping & genome sequencing
Related Conference of Pharmacogenomics: Convergence of Pharmacology & Genomics
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Modern Phenotypic Drug Discovery Defining the Path Forward D1
April 2 6 2016
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
February 21 25 2016
Molecular Medicine Tri-Conference 2016
March 6 - 11 2016
Cancer Center Business Summit 2016
February 24 - 25 2016
Molecular Diagnostics World Summit MolrDIAx 2016
May 19-20 2016
27th Annual Cancer Progress Conference 2016
March 8 - 9 2016
Personalized Diagnostics 2016
March 7 9 2016
Biobanking 2016
January 5-7 2016
GTCbio s Novel Immunotherapeutics Summit 2016
January 25 - 26 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
January 27-29 2016
African Pharmac 2016eutical Summit
February 24 - 25 2016
11th Annual Biomarkers Congress 2016
February 25 - 26 2016
Biomarkers Summit 2016
March 21 - 23 2016
10th Personalized Medicine World Congress 2016
January 24-27 2016
International Congress on Personalized Health Care
June 12 - 15 2016
Modern Phenotypic Drug Discovery Defining the Path Forward D1
April 2 6 2016
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
February 21 25 2016
Molecular Medicine Tri-Conference 2016
March 6 - 11 2016
Cancer Center Business Summit 2016
February 24 - 25 2016
Molecular Diagnostics World Summit MolrDIAx 2016
May 19-20 2016
27th Annual Cancer Progress Conference 2016
March 8 - 9 2016
Personalized Diagnostics 2016
March 7 9 2016
Biobanking 2016
January 5-7 2016
GTCbio s Novel Immunotherapeutics Summit 2016
January 25 - 26 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
January 27-29 2016
African Pharmac 2016eutical Summit
February 24 - 25 2016
11th Annual Biomarkers Congress 2016
February 25 - 26 2016
Biomarkers Summit 2016
March 21 - 23 2016
10th Personalized Medicine World Congress 2016
January 24-27 2016
International Congress on Personalized Health Care
June 12 - 15 2016
Pharmacogenomics: Convergence of Pharmacology & Genomics Conference Speakers
Recommended Sessions
- Advances In Molecular Diagnostics
- Approaches To Stem Cells
- Cardiology and vascular medicine
- Clinical Case Reports
- Genetics Of Ebola Outbreak
- Genomics & Personalized Medicine
- Immunology infectious disease
- Lifestyle Medicine
- Market Strategies & Challenges In Personalised Medicine
- Nanotechnology: Future Of Personalised Medicine
- Paths Of Biomarkers
- Personalised Medicine In 21st Century
- Personalized Drug Therapy
- Personalized Medicine & its Innovations
- Personalized oncology
- Pharmacogenomics: Convergence of Pharmacology & Genomics
- Preventive Medicines
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)